1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > T-Cell Lymphomas Global Clinical Trials Review, H1, 2014

T-Cell Lymphomas Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H1, 2014" provides data on the T-Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on T-Cell Lymphomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating T-Cell Lymphomas. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

T-Cell Lymphomas Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
T-Cell Lymphomas 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of T-Cell Lymphomas to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of T-Cell Lymphomas to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of T-Cell Lymphomas 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in T-Cell Lymphomas Therapeutics Clinical Trials 33
Prominent Drugs 35
Latest Clinical Trials News on T-Cell Lymphomas 36
Dec 06, 2013: Rhizen Pharmaceuticals announces initiation of a “First in Human” Phase-1 trial of RP6530, a dual PI3K delta/gamma inhibitor, in patients with hematological malignancies 36
Jan 24, 2013: Seattle Genetics And Millennium Initiate Global Phase III Clinical Trial Of Adcetris In Front-line CD30-Expressing Mature T-Cell Lymphoma 36
Dec 10, 2012: Infinity Pharma Reports IPI-145 Phase I Data Showing Clinical Activity In B-Cell And T-Cell Malignancies At ASH Annual Meeting 37
Dec 09, 2012: Millennium And Takeda Report Data From Phase I Trial Of Adcetris In Front-line Mature T-Cell Lymphomas 39
May 07, 2012: Millennium And Seattle Initiate Phase III Trial Of ADCETRIS In Patients With CD30-Expressing Relapsed Cutaneous T-cell Lymphoma 40
Clinical Trial Profiles 42
Clinical Trial Overview of Top Companies 42
Seattle Genetics, Inc. 42
Clinical Trial Overview of Seattle Genetics, Inc. 42
Celgene Corporation 44
Clinical Trial Overview of Celgene Corporation 44
Takeda Pharmaceutical Company Limited 46
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 46
Spectrum Pharmaceuticals, Inc. 48
Clinical Trial Overview of Spectrum Pharmaceuticals, Inc. 48
Amgen Inc. 49
Clinical Trial Overview of Amgen Inc. 49
Kirin Holdings Company, Limited 50
Clinical Trial Overview of Kirin Holdings Company, Limited 50
Bayer AG 51
Clinical Trial Overview of Bayer AG 51
Eisai Co., Ltd. 52
Clinical Trial Overview of Eisai Co., Ltd. 52
Infinity Pharmaceuticals, Inc. 53
Clinical Trial Overview of Infinity Pharmaceuticals, Inc. 53
Clinical Trial Overview of Top Institutes / Government 54
National Cancer Institute 54
Clinical Trial Overview of National Cancer Institute 54
Fred Hutchinson Cancer Research Center 59
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 59
The University of Texas M. D. Anderson Cancer Center 62
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 62
Samsung Medical Center 63
Clinical Trial Overview of Samsung Medical Center 63
Sun Yat-sen University 64
Clinical Trial Overview of Sun Yat-sen University 64
FUDAN University 65
Clinical Trial Overview of FUDAN University 65
University of Nebraska 66
Clinical Trial Overview of University of Nebraska 66
Memorial Sloan Kettering Cancer Center 67
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 67
University of Washington 68
Clinical Trial Overview of University of Washington 68
Children's Oncology Group 69
Clinical Trial Overview of Children's Oncology Group 69
Five Key Clinical Profiles 70
Appendix 101
Abbreviations 101
Definitions 101
Research Methodology 102
Secondary Research 102
About GlobalData 103
Contact Us 103
Disclaimer 103
Source 104

List of Tables
T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Region, 2014* 7
T-Cell Lymphomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
T-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
T-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
T-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
T-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
T-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
T-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of T-Cell Lymphomas to Oncology Clinical Trials, G7 Countries (%), 2014* 15
T-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
T-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of T-Cell Lymphomas to Oncology Clinical Trials, E7 Countries (%), 2014* 18
T-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
T-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Phase, 2014* 21
T-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
T-Cell Lymphomas Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
T-Cell Lymphomas Therapeutics, Global, Suspended Clinical Trials, 2014* 25
T-Cell Lymphomas Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
T-Cell Lymphomas Therapeutics, Global, Terminated Clinical Trials, 2014* 27
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 30
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 31
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 32
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 34
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 35
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Genetics, Inc., 2014* 42
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014* 44
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 46
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Pharmaceuticals, Inc., 2014* 48
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 49
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Kirin Holdings Company, Limited, 2014* 50
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 51
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 52
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Infinity Pharmaceuticals, Inc., 2014* 53
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 54
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014* 59
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 62
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014* 63
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014* 64
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2014* 65
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2014* 66
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 67
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 68
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 69

List of Figures
T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
T-Cell Lymphomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
T-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
T-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
T-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
T-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
T-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
T-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of T-Cell Lymphomas to Oncology Clinical Trials, G7 Countries (%), 2014* 15
T-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
T-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of T-Cell Lymphomas to Oncology Clinical Trials, E7 Countries (%), 2014* 18
T-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
T-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
T-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
T-Cell Lymphomas Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 30
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 31
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 32
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 33
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 35
GlobalData Methodology 102

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Epiomic Epidemiology Series: Hodgkin's Lymphoma Forecast in 17 Major Markets 2016-2026

Epiomic Epidemiology Series: Hodgkin's Lymphoma Forecast in 17 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Hodgkin’s Lymphoma in 17 Major Markets Hodgkin’s Lymphoma (HL) is a cancer (also known as Hodgkin Disease, Hodgkin Lymphoma o ...

Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market  Forecast-2023

Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the ...

Small lymphocytic lymphoma- Market Insights, Epidemiology and Market Forecast-2023

Small lymphocytic lymphoma- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Small lymphocytic lymphoma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the US

  • December 2016
    112 pages
  • Cancer  

  • United States  

    North America  

View report >

Cancer Statistics in Russia

  • November 2016
    8 pages
  • Leukemia  

    Cancer  

    Radiography  

  • Russian Federat...  

View report >

Colorectal Cancer Statistics in the US - Forecast

  • November 2016
    14 pages
  • Colorectal Canc...  

  • United States  

View report >

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.